25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
A clinical review of TB-500 (thymosin beta-4 active fragment) and its effects on liver function, including hepatoprotective mechanisms, fibrosis data, ALT/AST trends, and safety considerations for prescribers and patients.
Does TB-500 (thymosin beta-4 active fragment) change appetite or cravings? A clinician-level review of the mechanism, evidence base, reported effects, and what patients and prescribers need to know.
A physician-reviewed deep dive into TB-500 (thymosin beta-4 active fragment) and autoimmune disease: mechanistic risks, immune-modulation data, dosing cautions, and clinical decision points for patients with autoimmune conditions.
A clinician-level review of TB-500 (thymosin beta-4 active fragment) and its effects on bone health, fracture repair, osteoblast activity, and density. Covers mechanisms, key preclinical trials, compounding regulations, and clinical guidance.
A clinician-level review of thymosin beta-4 active fragment (TB-500) and cancer risk signals, covering preclinical tumor-promotion data, angiogenesis mechanisms, clinical gaps, and informed consent considerations for prescribers.
A physician-level review of TB-500 (thymosin beta-4 active fragment) cardiovascular effects, covering post-MI cardiac repair data, angiogenesis mechanisms, and what current evidence does and does not support for long-term use.
A clinician-level review of TB-500 (thymosin beta-4 active fragment) and its potential effects on cognitive function, neurogenesis, and brain repair, with primary-literature citations and a practical prescriber perspective.
A physician-reviewed comparison of compounded TB-500 (thymosin beta-4 active fragment) versus branded formulations, covering purity, dosing, regulatory status, clinical evidence, and how to choose the right source for your patients.
A GRADE-framework analysis of TB-500 (thymosin beta-4 active fragment) evidence across tissue repair, cardiac, and neurological endpoints. Understand what the data supports, where gaps exist, and what clinicians need to know before prescribing.
A physician-reviewed deep dive into how TB-500 (thymosin beta-4 active fragment) affects hair growth and skin repair, covering mechanisms, clinical and preclinical data, dosing, and safety considerations.
A physician-reviewed deep dive into TB-500 (thymosin beta-4 active fragment) and its potential effects on mental health, mood, neuroinflammation, and anxiety, with primary-literature citations and clinical context.
A clinician-level review of TB-500 (thymosin beta-4 active fragment) and its proposed effects on metabolism and energy expenditure, covering mechanism, available trial data, dosing, and safety signals.
A clinician-level review of TB-500 (thymosin beta-4 active fragment) microdosing protocols, dosing rationale, available human and animal trial data, safety considerations, and current compounding regulations.
A physician-reviewed deep dive into TB-500 (thymosin beta-4 active fragment) muscle preservation strategies, covering mechanism, dosing protocols, primary-literature evidence, and clinical decision frameworks.
Why TB-500 (thymosin beta-4 active fragment) stops working and how to fix it. MD-level guide covering dose titration, injection technique, compounding quality, cycling protocols, and biomarker monitoring.
A physician-reviewed clinical guide to thymosin beta-4 active fragment (TB-500) after bariatric surgery, covering wound healing, gut-lining repair, absorption changes, dosing considerations, and the current evidence base with primary-literature citations.
A clinician-level guide to the TB-500 (thymosin beta-4 active fragment) pre-surgery hold window, covering pharmacology, bleeding risk, angiogenic concerns, and protocol recommendations backed by primary literature.
A clinical review of what happens when you stop TB-500 (thymosin beta-4 active fragment), including rebound inflammation, tissue repair changes, angiogenesis reversal, and how to taper safely.
What is known---and not known---about TB-500 (thymosin beta-4 fragment), kidney claims, and regulatory status.
A physician-level guide to restarting TB-500 (thymosin beta-4 active fragment) after acute illness, covering timing, dosing, immune considerations, and primary-literature citations.
A clinician-level review of how season, temperature, UV exposure, training cycles, and immune fluctuations affect TB-500 (thymosin beta-4 active fragment) dosing, storage, and outcomes. Includes primary-literature citations, practical protocols, and a decision framework.
A physician-reviewed, evidence-based analysis of TB-500 (thymosin beta-4 active fragment) and its proposed mechanisms, current research status, and what compounded peptide users need to know about sexual function claims.
A clinical review of how TB-500 (thymosin beta-4 active fragment) may affect sleep architecture, slow-wave sleep, neuroinflammation, and recovery, with primary-source citations and physician-level analysis.
How to store, transport, and dose TB-500 (thymosin beta-4 active fragment) across time zones. Covers cold-chain logistics, TSA compliance, dosing schedule adjustments, and circadian considerations for compounded peptide travelers.
A physician-reviewed, week-by-week breakdown of what to expect during your first month on TB-500 (thymosin beta-4 active fragment), including dosing timelines, tissue-repair milestones, and primary-literature citations.